AT-533 NEW
| Price | $47 | $113 | $178 |
| Package | 1mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2024-11-11 |
Product Details
| Product Name: AT-533 | CAS No.: 908112-37-8 |
| Purity: 99.54% | Supply Ability: 10g |
| Release date: 2024/11/11 |
Product Introduction
Bioactivity
| 名稱 | AT-533 |
| 描述 | AT-533 is a potent inhibitor of Hsp90 and HSV. AT-533 blocks the HIF-1α/VEGF/VEGFR-2 signaling pathway, leading to suppress tumor growth and angiogenesis. AT-533 also inhibits the activation of the downstream pathways, including Erk1/2, FAK, Akt/mTOR/p70S6K,. AT-533 inhibits the cell migration, invasion, and the tube formation of human umbilical vein endothelial cells (HUVECs). |
| 體外活性 | AT-533 (0-1350 nM; 24h or 48h) inhibits 20 ng/mL VEGF-induced tube formation, cell migration, and HUVEC invasion. Additionally, AT-533 (2 μM or 75 μM; 24h) hinders the HIF-1α/VEGF signaling pathway in hypoxia-induced breast cancer cells and inhibits Akt/mTOR/p70S6K, Erk1/2, and FAK phosphorylation. It shows anti-angiogenic activity on the chorionic villus (CAM) model at 10 nM and 50 nM over 48h. Furthermore, AT-533 (0.5 μM; 2 or 4 hours) reduces TNF-α, IL-1β, and IL-6 production induced by HSV-1 in RAW264.7 and BV2 cells [1, 2]. |
| 體內活性 | AT-533 (10 mg/kg; intraperitoneal injection; once daily for 21 days) inhibited the expression of HIF-1α/VEGF signaling pathway-related proteins in a mouse MDA-MB-231 xenograft model of breast cancer [1]. AT-533 (1, 2, 4 mg/kg; intraperitoneal injection; once daily for 30 days) did not cause death, appetite loss, weight loss, or adverse reactions in subacute toxicity tests of Sprague Dawley rats [3]. |
| 存儲條件 | Shipping with blue ice. |
| 溶解度 | DMSO : 60 mg/mL (146.16 mM), Sonication is recommended. |
| 關鍵字 | AT 533 | AT533 | Benzamide,2[(trans4hydroxycyclohexyl)amino]4(4,5,6,7tetrahydro3,6,6trimethyl4oxo1Hindazol1yl) | AT-533 |
| 相關產品 | Floxuridine | Docusate sodium | Octyl gallate | 1-Docosanol | Oxytetracycline Hydrochloride | 2-Deoxy-D-glucose | S-Methylisothiourea sulfate | Oxyresveratrol | Idoxuridine | Acyclovir | Palmitic acid | Ganciclovir |
| 相關庫 | 外泌體相關化合物庫 | 經典已知活性庫 | 抗病毒庫 | 抑制劑庫 | 已知活性化合物庫 | 細胞骨架化合物庫 | 抗癌活性化合物庫 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $134.00/2mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-10-23 | |
| $1520.00/25mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-10-28 | |
| $0.00/1kg |
VIP5Y
|
Hebei Yanxi Chemical Co., Ltd.
|
2023-10-10 |
United States- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY